Empower GBM: A pilot study of a patient-caregiver supportive intervention for patients with glioblastoma.

IF 1.9 4区 医学 Q3 HEALTH POLICY & SERVICES
Karena Leo, Laura S Porter, Jodie Lisenbee, Katherine Ramos
{"title":"Empower GBM: A pilot study of a patient-caregiver supportive intervention for patients with glioblastoma.","authors":"Karena Leo, Laura S Porter, Jodie Lisenbee, Katherine Ramos","doi":"10.1017/S1478951525100436","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this article is to develop and pilot test a new supportive care intervention, Empower GBM, designed for patients with glioblastoma and their family caregivers to reduce psychological distress and improve quality of life.</p><p><strong>Methods: </strong>Qualitative interviews were conducted with patients diagnosed with glioblastoma and their caregivers to obtain information about their experiences and needs in coping with glioblastoma. We also gathered their feedback about the supportive care intervention we were proposing (Phase I). Following Phase I, we conducted a single-arm pilot to evaluate the feasibility and acceptability of the 6-session intervention (Phase II).</p><p><strong>Results: </strong>During interviews (<i>N</i> = 14), patients and caregivers reported having the most difficulty and distress surrounding disease progression and management, maintaining dignity and autonomy, negotiation of roles and responsibilities, and maintaining connection with one another. Participants endorsed that an intervention like Empower GBM with skills focused on managing symptoms to increase independence, increasing caregiving efficacy and support, and coping with dyadic challenges would be of potential benefit. Preliminary results from the pilot study (<i>N</i> = 11) suggested the intervention is both feasible (e.g., 82% completed all 6 sessions and post-treatment surveys) and acceptable (88.9% reported a mean satisfaction score of 3 or higher; mean score of 3.57/4.0). Improvements in psychological outcomes, functional well-being, and caregiving efficacy from pre- to post-treatment survey results suggested the potential benefits of the intervention.</p><p><strong>Significance of results: </strong>We developed a novel supportive care intervention informed by the dyadic illness model that is designed to meet the individual and interpersonal needs of patients with glioblastoma and their caregivers. Unique features include its flexibility to be delivered to patients and/or their family caregivers individually or jointly, while providing skills and strategies to meet the needs of both individuals and the dyad as the unit of care in coping with glioblastoma.</p>","PeriodicalId":47898,"journal":{"name":"Palliative & Supportive Care","volume":"23 ","pages":"e136"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Palliative & Supportive Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S1478951525100436","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The aim of this article is to develop and pilot test a new supportive care intervention, Empower GBM, designed for patients with glioblastoma and their family caregivers to reduce psychological distress and improve quality of life.

Methods: Qualitative interviews were conducted with patients diagnosed with glioblastoma and their caregivers to obtain information about their experiences and needs in coping with glioblastoma. We also gathered their feedback about the supportive care intervention we were proposing (Phase I). Following Phase I, we conducted a single-arm pilot to evaluate the feasibility and acceptability of the 6-session intervention (Phase II).

Results: During interviews (N = 14), patients and caregivers reported having the most difficulty and distress surrounding disease progression and management, maintaining dignity and autonomy, negotiation of roles and responsibilities, and maintaining connection with one another. Participants endorsed that an intervention like Empower GBM with skills focused on managing symptoms to increase independence, increasing caregiving efficacy and support, and coping with dyadic challenges would be of potential benefit. Preliminary results from the pilot study (N = 11) suggested the intervention is both feasible (e.g., 82% completed all 6 sessions and post-treatment surveys) and acceptable (88.9% reported a mean satisfaction score of 3 or higher; mean score of 3.57/4.0). Improvements in psychological outcomes, functional well-being, and caregiving efficacy from pre- to post-treatment survey results suggested the potential benefits of the intervention.

Significance of results: We developed a novel supportive care intervention informed by the dyadic illness model that is designed to meet the individual and interpersonal needs of patients with glioblastoma and their caregivers. Unique features include its flexibility to be delivered to patients and/or their family caregivers individually or jointly, while providing skills and strategies to meet the needs of both individuals and the dyad as the unit of care in coping with glioblastoma.

授权GBM:一项针对胶质母细胞瘤患者的患者-护理人员支持干预的试点研究。
目的:本文的目的是开发和试点测试一种新的支持性护理干预,Empower GBM,专为胶质母细胞瘤患者及其家庭照顾者设计,以减少心理困扰,提高生活质量。方法:对胶质母细胞瘤患者及其护理人员进行定性访谈,了解其应对胶质母细胞瘤的经历和需求。我们还收集了他们对我们建议的支持性护理干预(第一阶段)的反馈。在第一阶段之后,我们进行了一项单臂试验来评估6期干预的可行性和可接受性(第二阶段)。结果:在访谈中(N = 14),患者和护理人员报告在疾病进展和管理,维护尊严和自主权,角色和责任谈判以及保持彼此联系方面存在最大的困难和困扰。与会者认为,像赋权GBM这样的干预措施,其技能侧重于管理症状,以提高独立性,提高护理效力和支持,并应对双重挑战,将具有潜在的好处。试点研究(N = 11)的初步结果表明,干预是可行的(例如,82%的患者完成了所有6次治疗和治疗后调查)和可接受的(88.9%的患者报告平均满意度得分为3分或更高;平均评分3.57/4.0)。从治疗前到治疗后的调查结果来看,心理结果、功能健康和护理效果的改善表明了干预的潜在益处。研究结果的意义:我们开发了一种新的支持性护理干预,该干预是根据二元疾病模型设计的,旨在满足胶质母细胞瘤患者及其护理人员的个体和人际需求。独特的特点包括它的灵活性,提供给患者和/或他们的家庭照顾者单独或共同,同时提供技能和策略,以满足个人和二人组的需求,作为治疗胶质母细胞瘤的单位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Palliative & Supportive Care
Palliative & Supportive Care HEALTH POLICY & SERVICES-
CiteScore
4.10
自引率
9.10%
发文量
280
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信